Reverse payment patent settlements in the pharmaceutical sector and competition law – do Lundbeck and Actavis help to bridge the views across the Atlantic regarding the delayed market entry of cheaper, generic medicines?

statement of authorship
P. Dutt, T. Kerikmäe
journal volume number month
Vol. 13, 1
year of publication
pages
p. 21-36
ISSN
1213-8770
language
inglise
Dutt, P.K., Kerikmäe, T. Reverse payment patent settlements in the pharmaceutical sector and competition law – do Lundbeck and Actavis help to bridge the views across the Atlantic regarding the delayed market entry of cheaper, generic medicines? // International and comparative law review (2013) Vol. 13, 1, p. 21-36.